Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amro Badr

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
BMC Cardiovascular Disorders|February 8, 2025
Prevalence of adherence and its impact on quality of life in oral anticoagulant users in Egypt: A cross-sectional study from two Egyptian university hospitalsMohamed Terra, Amro Badr, Mohamed Baklola, et al.
The Neurologist|February 9, 2026
Optical Coherence Tomography Abnormalities in NOTCH3 Mutation Carriers: A Matched Case-Control Study From UK BiobankSai Krishna Vallamchetla, Amro Badr, Xin Li, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|March 11, 2026
Predictors of Higher Mavacamten Maintenance Dose in Obstructive Hypertrophic CardiomyopathyMustafa Suppah, Humam Abo Abdullah, Amro Badr, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|February 17, 2025
Rethinking Risk in Hypertrophic Cardiomyopathy: Assessing the Role of Myocardial Fibrosis and Left Ventricular Hypertrophy in Sudden Cardiac DeathAmro Badr, Juan Farina, Reza Arsanjani, et al.
Biomedicines|April 29, 2025
Temporal Patterns of Holter-Detected Arrhythmias in Hypertrophic Cardiomyopathy Patients Treated with MavacamtenAmro Badr, Kaitlin Roehl, Mustafa Suppah, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|January 8, 2025
Reevaluating Normal-Flow Low-Gradient Severe Aortic Stenosis: Clinical Phenotypes and Outcomes in Severe Aortic Stenosis Among Transcatheter Aortic Valve Replacement PatientsAmro Badr, Mustafa Suppah, Kamal Awad, et al.
Coronary Artery Disease|January 8, 2025
Controlled low-density lipoprotein cholesterol attenuates cardiovascular risk mediated by elevated lipoprotein(a) after percutaneous coronary interventionAhmed K Mahmoud, Kamal Awad, Juan M Farina, et al.
European Journal of Preventive Cardiology|February 7, 2025
Elevated Lipoprotein(a) Levels Linked to New-Onset Atrial Fibrillation: Insights from a Retrospective Cohort StudyKamal Awad, Moaz Kamel, Ahmed K Mahmoud, et al.
International Journal of Cardiology|February 16, 2025
The association of bisphosphonates, calcium levels and PTH levels with bioprosthetic aortic valve degenerationMohammed Tiseer Abbas, Juan M Farina, Kamal Awad, et al.
Journal of the American Heart Association|July 3, 2026
Timing of Antithrombotic Therapy Among Patients With Hemorrhagic Transformation After an Ischemic StrokeSeyyed Sina Hejazian, Shima Shahjouei, Sasan Bahrami, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BMC Cardiovascular Disorders|February 8, 2025
Prevalence of adherence and its impact on quality of life in oral anticoagulant users in Egypt: A cross-sectional study from two Egyptian university hospitalsMohamed Terra, Amro Badr, Mohamed Baklola, et al.
The Neurologist|February 9, 2026
Optical Coherence Tomography Abnormalities in NOTCH3 Mutation Carriers: A Matched Case-Control Study From UK BiobankSai Krishna Vallamchetla, Amro Badr, Xin Li, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|March 11, 2026
Predictors of Higher Mavacamten Maintenance Dose in Obstructive Hypertrophic CardiomyopathyMustafa Suppah, Humam Abo Abdullah, Amro Badr, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|February 17, 2025
Rethinking Risk in Hypertrophic Cardiomyopathy: Assessing the Role of Myocardial Fibrosis and Left Ventricular Hypertrophy in Sudden Cardiac DeathAmro Badr, Juan Farina, Reza Arsanjani, et al.
Biomedicines|April 29, 2025
Temporal Patterns of Holter-Detected Arrhythmias in Hypertrophic Cardiomyopathy Patients Treated with MavacamtenAmro Badr, Kaitlin Roehl, Mustafa Suppah, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|January 8, 2025
Reevaluating Normal-Flow Low-Gradient Severe Aortic Stenosis: Clinical Phenotypes and Outcomes in Severe Aortic Stenosis Among Transcatheter Aortic Valve Replacement PatientsAmro Badr, Mustafa Suppah, Kamal Awad, et al.
Coronary Artery Disease|January 8, 2025
Controlled low-density lipoprotein cholesterol attenuates cardiovascular risk mediated by elevated lipoprotein(a) after percutaneous coronary interventionAhmed K Mahmoud, Kamal Awad, Juan M Farina, et al.
European Journal of Preventive Cardiology|February 7, 2025
Elevated Lipoprotein(a) Levels Linked to New-Onset Atrial Fibrillation: Insights from a Retrospective Cohort StudyKamal Awad, Moaz Kamel, Ahmed K Mahmoud, et al.
International Journal of Cardiology|February 16, 2025
The association of bisphosphonates, calcium levels and PTH levels with bioprosthetic aortic valve degenerationMohammed Tiseer Abbas, Juan M Farina, Kamal Awad, et al.
Journal of the American Heart Association|July 3, 2026
Timing of Antithrombotic Therapy Among Patients With Hemorrhagic Transformation After an Ischemic StrokeSeyyed Sina Hejazian, Shima Shahjouei, Sasan Bahrami, et al.
Pageof 1